A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate in subjects suffering from nocturnal asthma, the
efficacy and safety of modified release Prednisone on signs and symptoms.